Latest Pyrazines Stories
An Extensive UCSF Study Questions Previous Study’s Analytic Methods San Francisco, CA (PRWEB) May 05, 2012 A popular smoking cessation medication has
A popular smoking cessation medication has been under a cloud of suspicion ever since the Canadian Medical Association Journal (CMAJ) published a study in July 2011 reporting "risk of serious adverse cardiovascular events associated with varenicline."
Tokyo, Apr 17, 2012 - (JCN Newswire) - Eisai Co., Ltd.
Tokyo, Jan 18, 2012 - (JCN Newswire) - Eisai Co.
The poor safety profile of the smoking-cessation drug varenicline (Chantix™) makes it unsuitable for first-line use.
- A political dynamiter.